Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Clin Cancer Res. 2019 May 15;25(10):3193. doi: 10.1158/1078-0432.CCR-19-1098.
No abstract available

Publication types

  • Published Erratum